Chinese investors’ exit may not be a bad thing

Why read this story?

Editor's note: In the last couple of days, there have been reports of at least two large Chinese investors looking to exit or reduce their investments in Indian companies. The Fosun Group was reported to be considering the sale of its controlling stake in Hyderabad-based drugmaker Gland Pharma while two subsidiaries of Alibaba were keen to pare their investments in Zomato through open market sales (a block deal for over 3% of the food delivery company’s shares took place on Wednesday). Even Xiaomi Corp. was reported to be looking to exit its investments in the Indian startup ecosystem.  Normally, these actions wouldn’t really make headlines. Fosun is a large conglomerate that is reeling under debt back home. So it should be par for the course for it to shed some of its global investments. Likewise, Alibaba has been an early investor in Zomato and it isn’t unusual for it to  sell a part of its stake now that the food delivery firm has listed. As for Xiaomi, India has been anything but a smooth ride, especially after the seizure of over Rs …